Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Mucopolysaccharidosis type 3A

MONDO:0009655

A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme heparan sulfate sulfatase. It is characterized by behavioral changes, sleep disturbances, mental developmental delays and seizures.

Also known as: MPS III A, MPS3A, MPSIIIA, Sanfilippo A, Sanfilippo syndrome a, Sanfilippo syndrome type A, heparan sulfamidase deficiency, mucopolysaccharidosis type 3A

8 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Musculoskeletal system disorder (207) Hereditary disease (176) Bone disorder (51) Inborn errors of metabolism (45) Lysosomal storage disease (35) Syndromic disease (25) Human disease (14) Mucopolysaccharidosis (13)
Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 4 Completed 1
Sort by
  • One-Time gene therapy aims to halt fatal brain disease in children

    Disease control Recruiting now

    This trial tests a one-time gene therapy called UX111 for children with Sanfilippo A, a rare genetic disorder that causes severe brain damage. The therapy delivers a working copy of the missing gene to cells. Researchers will measure whether it reduces harmful substances in the b…

    Phase: PHASE2, PHASE3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control

    Last updated Jul 19, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space